Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS
Date:5/7/2013

ve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with maintaining and increasing sales of and revenue from Xyrem, such as the potential introduction of generic competition and changed or increased regulatory restrictions on or requirements with respect to Xyrem, as well as similar risks related to effectively commercializing the company's other marketed products, including Erwinaze and Prialt; protecting the company's intellectual property rights; obtaining appropriate pricing and reimbursement for the company's products in an increasingly challenging environment; ongoing regulation and oversight by U.S. and non-U.S. regulatory agencies; dependence on key customers and sole source suppliers, including the risk that the company may be unable to timely resolve potential product supply shortages and meet product demand; the difficulty and uncertainty of pharmaceutical product development and the uncertainty of clinical success and regulatory approval; the company's ability to identify and acquire, in-license or develop additional products or product candidates to grow its business; and potential restrictions on the company's ability and flexibility to pursue future opportunities as a result of its substantial outstanding debt obligations; as well as risks related to future opportunities and plans, including the uncertainty of expected future financial performance and results; and those risks detailed from time-to-time under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals plc's Securities and Exchange Commission filings and reports (Commission File No. 001-33500), including in the Annual Report on Form 10-K for the year ended December 31, 2012 and future filings and reports by the company, including the Quarterly Report on Form
'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
3. Kinex Pharmaceuticals and Zenith Technology Corporation announce the execution of a collaborative licensing agreement
4. Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
5. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
6. Valeant Pharmaceuticals Provides Efinconazole Update
7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
8. Cumberland Pharmaceuticals Reports First Quarter Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
10. Webcast Alert: Isis Pharmaceuticals First Quarter 2013 Financial Results Conference Call
11. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015 Stand Up To Cancer ... of a $20 million Dream Team to attack the number ... the Annual Meeting of the American Association for Cancer Research ... that 221,000 people in the United States ... 2015, and 158,040 will die from it, making lung cancer ...
(Date:4/20/2015)... 20, 2015 Kalorama Information says that ... to be robust; the market is driven by ... global markets, new product innovations and increasing life ... market inhibitors, such as government restraints, limited hospital ... The healthcare market research publisher,s report, Insulin ...
(Date:4/20/2015)... INDIANAPOLIS , April 20, 2015 Eli ... that the investigational medicine ixekizumab was statistically superior to ... arthritis (PsA), as demonstrated by the proportion of patients ... standard assessment that represents a 20 percent reduction in ... College of Rheumatology response criteria. During the 24-week, Phase ...
Breaking Medicine Technology:New SU2C-American Cancer Society Lung Cancer Dream Team Announced 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 3New SU2C-American Cancer Society Lung Cancer Dream Team Announced 4New SU2C-American Cancer Society Lung Cancer Dream Team Announced 5New SU2C-American Cancer Society Lung Cancer Dream Team Announced 6Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 2Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 3Lilly's Ixekizumab Met Primary Endpoint in a Phase 3 Study Investigating the Treatment of Psoriatic Arthritis 4
... 7 With the growth in the home health care ... Entertainment 2009® that it is offering OnCare by Xora, an ... helps address the specific needs of mobile health care workers ... , Designed specifically for use by home caregivers who travel ...
... Oct. 7 Odyssey Thera, Inc. announced that it ... Pfizer Inc. following Pfizer,s decision to progress drug candidates ... alliance with Pfizer announced in August, 2006. These milestones ... for the advancement of specific drug candidates, and follow ...
Cached Medicine Technology:Verizon Wireless Offers Home Health Care Industry Custom Mobile Application To Be More Productive 2
(Date:4/21/2015)... The Northeast Football Clinic (NEFC) has trained ... school in Byfield, MA. Applications are being accepted for ... grades 6-12. , The outstanding professional, college, and high ... , Offensive and defensive linemen and linebackers ... most unsung positions on the field, the the success ...
(Date:4/21/2015)... 2015 Freeslate, Inc ., the ... today announced that the Centre for Catalysis Research ... has acquired a Freeslate Core Module 3 (CM3) ... (SPR) to accelerate current research programs. The systems ... they will be available to academic users and industrial ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 This ... pathologists, physical therapist assistants, occupational therapist assistants, teachers, ... and techniques to help children across the autism ... through Education Resources Inc. , ... 2008, this highly acclaimed yoga curriculum addresses learning ...
(Date:4/20/2015)... Draft, Virginia (PRWEB) April 20, 2015 ... Augusta Health facility in Stuarts Draft, an independent, ... County, Staunton, and Waynesboro, Virginia. The project was ... Architects. The Stuarts Draft facility is expected to ... , Located on Stuarts Draft Highway, the new ...
(Date:4/20/2015)... April 21, 2015 The National ... Binau, Founder of Soul Care Group, Inc., as ... is recognized with this prestigious distinction for leadership in ... Local Chapters, NAPW is the nation's leading networking organizaiton ... Susan with our Woman of the Year Award,” says ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2Health News:National Association of Professional Women Announces Susan Binau, Founder of Soul Care Group, Inc., a 2015 Professional Woman of the Year 2
... ... a national class action in Federal court. The suit challenges Obamacare on the basis that ... the courts to re-evaluate the Commerce clause precedent, arguing that current precedent in effect destroys ... ...
... Mo April 19, 2010 Approximately 7 percent of ... are infected with the fungus Trichophyton tonsurans ( ... U.S., according to a new study published today in ... at defining infection prevalence of the scalp fungus in children ...
... Study found multivitamins, calcium tablets had protective effect , ... multivitamin tablets along with calcium supplements seem to have ... suggests. , The authors of the study, which ... for Cancer Research annual conference in Washington, D.C., did ...
... ... Gurnick Academy of Medical Arts, Radiologic Technology program ... Joint Review Committee on Education in Radiologic Technology (JRCERT). This ... program’s curriculum, clinical education process, teaching methodologies, and course content. ...
... ... pornography addictions, S.A. Lifeline Foundation has launched a brand new website that offers assistance and ... Lehi, ... epidemic of porn addiction is on a steady rise. Knowing this, Utah based ...
... overweight much earlier in life than in past generations, study ... are getting heavier at an earlier age and failing to ... chronic illness and life expectancy will be worse than previously ... five people born between 1966 and 1985 became obese -- ...
Cached Medicine News:Health News:Over 10,000 Americans Join Lawsuit Against Obamacare 2Health News:Over 10,000 Americans Join Lawsuit Against Obamacare 3Health News:Study finds treatment-resistant ringworm prevalent among children in metro elementary schools 2Health News:Supplements Might Reduce Breast Cancer Risk 2Health News:Supplements Might Reduce Breast Cancer Risk 3Health News:Gurnick Academy of Medical Arts, Radiologic Technology Program Earns JRCERT Accreditation 2Health News:S.A. Lifeline Foundation Offers New and Improved Website for Those with Pornography Addictions 2Health News:Obesity Epidemic May Cut Life Spans of Young Adults 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: